THERADIAG

Combined General Meeting of May 14, 2020

Regulatory News:

THERADIAG (ISIN: FR0004197747, Ticker: ALTER) (Paris:ALTER), which specializes in in vitro diagnostics and theranostics, today announces that its Annual General Meeting convened on May 14, 2020 could not validly conduct business due to the quorum required not being reached, and that a new Annual General Meeting will be convened to vote on the same agenda on June 25, 2020 at 2:00pm in closed session, without shareholders or other people allowed to assist being physically present.

As stated in the press release published by the Company on April 21, 2020, due to the ongoing Covid-19 pandemic, the Annual General Meeting held today and chaired by Mr. Pierre Morgon, Chairman of the Theradiag Board of Directors, took place in closed session, with shareholders being given the option to attend via a conference call.

Shareholders who voted by post or who appointed a proxy together represented 879 054 shares with voting rights attached, out of the 8 629 002 shares comprising the share capital with voting rights attached. Given that the quorum accounted for 10.817 % of the share capital, the Annual General Meeting could not therefore validly conduct business. As such, without the quorum required to vote on ordinary and extraordinary resolutions, none of the resolutions submitted was put to a vote.

Shareholders are hereby informed that an Annual General Meeting on second call will be convened on June 25, 2020 at 2:00pm. In the same way, the latter will be held in closed session, without shareholders being physically present, and will address the same agenda. A second notice of meeting will be published on May 22, 2020 in the French official legal announcement publication BALO.

All documents relating to the General Meeting are being made available in French on the Company’s website within the legal deadlines (https://www.theradiag.com/assemblee-generale).

If you are a Theradiag shareholder and wish to participate in voting on resolutions, you may:

• vote by internet, via the VOTACCESS platform: this method is highly recommended in light of the ongoing Covid-19 health crisis. This platform will be open for the second AGM from May 22, 2020 until June 24, 2020 at 3:00pm.
• vote by proxy or by post, pursuant to the terms set out in the second notice of meeting. The votes will be taken into account until June 22, 2020 included.

A voting guide in French, containing all the terms and conditions as well as the voting deadlines for the General Meeting on second call will be made available to all shareholders on the company's website on May 22, 2020.